Navigation Links
Melanoma treatment options 1 step closer
Date:10/20/2009

A targeted chemotherapy for the treatment of skin cancer is one step closer, after a team of University of Alberta researchers successfully synthesized a natural substance that shows exceptional potential to specifically treat this often fatal disease.

U of A chemistry professor Dennis Hall said after three years of work, his research team has successfully produced the substance called Palmerolide A.

"The potency of palmerolide is exceptional and melanoma is a very aggressive cancer for which there is almost no chemotherapeutic recourse," said Hall. "Natural substances like palmerolide offer real hope for such treatments.

"Current chemotherapy as an overall strategy is not very effective in treating melanoma. Less than a quarter of patients respond to chemotherapy and it typically only works for less than a year, and it has little to no effect on survival time. Palmerolide A as a targeted therapy may prove to be more effective [for treatment] with less toxicity," said Hall.

"One of the problems with most cancer drugs is the lack of selectivity for cancer cells versus normal cells. Preliminary data for Palmerolide A looks very promising in terms of solving this issue," he said.

"For commercialization, the structure needs to be made more 'drug-like;' smaller and more water-soluble, while preserving the potency," said Hall, who is optimistic that his U of A team is moving forward in the race to develop a treatment for melanoma.


'/>"/>

Contact: Wanda Vivequin
wanda.vivequin@ualberta.ca
780-492-4073
University of Alberta
Source:Eurekalert

Page: 1

Related biology news :

1. Trial of new treatment for advanced melanoma shows rapid shrinking of tumors
2. Study shows cancer vaccines led to long-term survival for patients with metastatic melanoma
3. Zebrafish provide a model for cancerous melanoma in humans
4. New method for detection of phosphoproteins reveals regulator of melanoma invasion
5. NYU Langone Medical Center researchers find micro RNA plays a key role in melanoma metastasis
6. Stress may hasten the growth of melanoma tumors
7. GUMC researchers find gene function lost in melanoma and glioblastoma
8. Vitiligo skin disorder could yield clues in fight against melanoma
9. Variant of vitamin D receptor gene linked to melanoma risk
10. As rates rise, researchers find better way to identify melanoma
11. New study shows Dermytol produces pronounced decrease in malignant melanoma tumor volume
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2017)... 27, 2017  Catholic Health Services (CHS) has ... Society (HIMSS) Analytics for achieving Stage 6 on ... . In addition, CHS previously earned a place ... an electronic medical record (EMR). "HIMSS ... of EMR usage in an outpatient setting.  This ...
(Date:3/22/2017)... March 21, 2017   Neurotechnology , a ... technologies, today announced the release of the ... provides improved facial recognition using up to 10 ... single computer. The new version uses deep neural-network-based ... and it utilizes a Graphing Processing Unit (GPU) ...
(Date:3/16/2017)... 16, 2017 CeBIT 2017 - Against identity fraud with DERMALOG solutions ... ... Used combined in one project, multi-biometric solutions provide a crucial contribution against ... Used combined in one project, ... ...
Breaking Biology News(10 mins):
(Date:3/29/2017)... , March 29, 2017  Halozyme Therapeutics, ... oncology and drug-delivery therapies, today announced that an ... and Drug Administration voted 11 to 0 that ... skin) injection was favorable for patients in the ... lymphoma and chronic lymphocytic leukemia. The FDA action ...
(Date:3/29/2017)... ... March 29, 2017 , ... Bactana Animal Health, a company developing ... food supply through enhancement of the gut microbiota, today announced the closing of its ... , New York-based Sustainable Income Capital Management, LLC and a number of private investors. ...
(Date:3/29/2017)... , March 29, 2017 /PRNewswire/ -  GeneNews Limited (TSX:GEN) ... BreastSentry™ , a new risk stratification test for breast cancer, ... Innovative Diagnostics Laboratory ("IDL"). BreastSentry incorporates a blood-based biomarker test ... lifetime risk for developing breast cancer.   ... BreastSentry measures the fasting ...
(Date:3/28/2017)... ... 28, 2017 , ... NetDimensions announced today that Scandinavian Health ... plan management for consistent implementation of standards and regulatory requirements across SHL companies ... help improve and streamline their training and employee development programs, which are critical ...
Breaking Biology Technology: